Paydirt
SION
Ticker

Sionna Therapeutics, Inc.

SION · Healthcare · Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibros…

Sionna Therapeutics, Inc. (SION), in the Healthcare sector, has 31 disclosed filings on Paydirt over the trailing twelve months from 10 corporate insiders: 0 purchases and 31 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 17 and filed Sep 21. The most active filer was Peter A. Thompson with 9 filings.

Add to watchlist
Filings, ttm
31
0 buys · 31 sells
Traders, ttm
10
10 insiders
Volume, ttmiDollar value disclosed in the window
$190.8M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Sep 17
Filed today
ADViAverage daily dollar volume
$10.0M
market data
Share price · 12M
$5.59 (-78.4%)
$51.04$27.77$4.50Sep 22 2025Mar 10Aug 24

Adjusted for splits and dividends.

Volume by month
$62.5M$31.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · buys $62.5MJul 2025 · buys $950KAug 2025 · sells $2.7MSep 2025 · sells $1.2MOct 2025 · sells $40.9MNov 2025 · sells $15.5MDec 2025 · sells $3.4MJan 2026 · sells $10.0MFeb 2026 · sells $2.6MMar 2026 · sells $347KApr 2026 · sells $50.8MMay 2026 · sells $26.7MJul 2026 · sells $18.7MSep 2026 · sells $21.8M
Buys $63.4M Sells $194.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
PT Peter A. Thompson Director 9 filings BB Bruce Booth Director 6 filings OL Orbimed Advisors Llc Director 6 filings MC Michael Cloonan President & CEO 5 filings JF Jennifer Fitzpatrick Chief Legal Officer 4 filings OL OrbiMed Capital GP VIII LLC Director 3 filings ER Elena Ridloff Director 3 filings RP Ra Capital Management, L.P. Director 2 filings
Recent filings
Ra Capital Management, L.P.SALE Director $21.8M
3,448,811 sh across 2 lots
Exec Sep 17
Filed Sep 21 · 6:56 PM ET
Peter A. ThompsonSALE Director $3.9M
85,918 sh × $44.86
Exec Jul 7
Filed Jul 9 · 4:47 PM ET
Orbimed Advisors LlcSALE Director $3.9M
85,918 sh × $44.86
Exec Jul 7
Filed Jul 9 · 4:44 PM ET
Jennifer FitzpatrickSALE Chief Legal Officer $447K
10,250 sh × $43.60
Exec Jul 6
Filed Jul 7 · 4:38 PM ET
Peter A. ThompsonSALE Director $5.3M
115,844 sh × $45.50
Exec Jun 30
Filed Jul 2 · 4:45 PM ET
Orbimed Advisors LlcSALE Director $5.3M
115,844 sh × $45.50
Exec Jun 30
Filed Jul 2 · 4:42 PM ET
Orbimed Advisors LlcSALE Director $13.4M
292,952 sh across 3 lots
Exec May 7
Filed May 11 · 5:30 PM ET
Peter A. ThompsonSALE Director $13.4M
292,952 sh across 3 lots
Exec May 7
Filed May 11 · 5:30 PM ET
Orbimed Advisors LlcSALE Director $2.5M
55,345 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET
Peter A. ThompsonSALE Director $2.5M
55,345 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET
Orbimed Advisors LlcSALE Director $22.9M
510,583 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET
Peter A. ThompsonSALE Director $22.9M
510,583 sh across 3 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET
Jennifer FitzpatrickSALE Chief Legal Officer $347K
10,250 sh × $33.86
Exec Mar 5
Filed Mar 6 · 5:30 PM ET
OrbiMed Capital GP VIII LLCSALE Director $1.3M
29,063 sh × $44.58
Exec Feb 3
Filed Feb 4 · 5:30 PM ET
Peter A. ThompsonSALE Director $1.3M
29,063 sh × $44.58
Exec Feb 3
Filed Feb 4 · 5:30 PM ET
Jon WinkelriedSALE 10% owner $10.0M
250,000 sh × $40.00
Exec Jan 22
Filed Jan 26 · 5:30 PM ET
Peter A. ThompsonSALE Director $1.5M
33,356 sh × $44.55
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET
OrbiMed Capital GP VIII LLCSALE Director $1.5M
33,356 sh × $44.55
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET
Jennifer FitzpatrickSALE Chief Legal Officer $415K
10,250 sh × $40.52
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET
Peter A. ThompsonSALE Director $4.7M
106,473 sh across 2 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET
Orbimed Advisors LlcSALE Director $4.7M
106,473 sh across 2 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET
Peter KolchinskySALE Director $947K
23,973 sh across 3 lots
Exec Nov 21 2025
Filed Nov 24 2025 · 5:30 PM ET
Ra Capital Management, L.P.SALE Director $5.0M
124,870 sh across 10 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET
RA Capital Nexus Fund III, L.P.SALE Director $14.8M
373,610 sh across 8 lots
Exec Oct 24 2025
Filed Oct 28 2025 · 5:30 PM ET
Michael CloonanSALE President & CEO $3.6M
99,800 sh across 4 lots
Exec Oct 21 2025
Filed Oct 22 2025 · 5:30 PM ET